Navigation Links
Bedrocan Canada Statement Regarding Canadian Medical Association Motion on Smoking Marijuana
Date:8/22/2014

TORONTO, Aug. 22, 2014 /CNW/ - On Aug. 20, at its annual meeting in Ottawa, the Canadian Medical Association (CMA) voted on and approved a delegate resolution opposing the smoking of any plant material, including medicinal cannabis. Bedrocan Cannabis Corp., a leading Canadian licensed producer of medicinal cannabis is supportive of the CMA motion.

The CMA is quite right to point out that there are particular hazards associated with smoking any plant material, including medicinal cannabis. While some patients, particularly those who use small quantities, choose to smoke medicinal cannabis, the preferred method of delivery is via the use of a vaporizer – a device that heats cannabis to release the cannabinoids (the active ingredients), but does not burn it. There is good clinical evidence to show that vaporized cannabis contains significantly lower levels of toxins and harmful chemicalsi.

In addition, there is one medicinal cannabis vaporizer, the Vapormed Volcano Medic®, approved in Canada as a class 2 medical device. The use of a vaporizer allows patients to use cannabis to manage the symptoms of health conditions such as chronic pain, multiple sclerosis, anxiety, insomnia and other conditions, while avoiding the degree of risk involved in smoking a plant product.

This is an important distinction, because there is clinical value in patients being able to use medicinal cannabis via inhalation. Because the cannabis vapor is absorbed through the lining of the lungs, this method has a rapid onset of therapeutic effect, and allows patients to relatively effectively control dosageii.

It is entirely appropriate, and consistent with the mission of the CMA, to warn patients of the hazards of smoking a plant product. It is also important to note that a safer alternative – vaporization – does exist, and is being used by an increasing number of Health Canada registered medicinal cannabis patients.

About Bedrocan

Bedrocan is the global leader in medicinal cannabis research and product innovation and has been producing and supplying government-regulated medicinal cannabis for 13 years. Bedrocan's strains of pharmaceutical-grade cannabis are used by patients in seven countries, including Canada. The company is committed to clinical research, with ISO 9001-rated production processes and product development, on an international scale. Bedrocan is one of only two companies currently supplying pharmaceutical-grade medicinal cannabis in Canada

__________________________________
iPomahacova B, Van der Kooy F, Verpoorte R; "Canabis smoke condensate III: The cannabinoid content of vaporized Cannabis sativa"; Inhalation Toxicology, 21(13): 1108-1112, 2009
iiHazekamp A, Ruhaak R, Zuurman L, Van Gerven J, Verpoorte R; "Evaluation of a vaporizing device (Volcano®) for the pulmonary administration of tetrahydrocannabinol", Journal of Pharmaceutical Sciences; Vol. 95, No. 6, June 2006



'/>"/>
SOURCE Bedrocan Cannabis Corp
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Senior Life Sciences Executives Join Bedrocan as Independent Directors
2. Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017
3. Canada Ureteroscopes Market Outlook to 2020
4. Cannabis Science In Final Negotiations To Establish Its First Medical Cannabis Facilities In Canada
5. Canada Endoscopy Visualization Systems Market Outlook to 2020
6. InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada
7. EndoChoice Announces Health Canada License for Fuse Endoscopy System in Canada
8. Ensil Canada is Launching a New Medical Device: Publicly Traded Companies Are Invited to Acquire This Technology or Partner with Ensil Canada on the Marketing and Distribution of This New Device
9. Medbox Executes Consulting Agreement with Licensed Medical Cannabis Laboratory and Cultivation Center in Canada
10. First Financial Expands into Canada to Meet Increasing Demand for its Leasing Solutions
11. JenaValve Announces First Implantations Of Transapical TAVI System In Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  American Respiratory Labs (ARL), a ... now able to perform sophisticated lung assessments in patients, homes, thanks ... Inc. Patients are no longer limited to having ... PRO ® , ARL patients like Jeanne R. of ... the comfort of her own home. ...
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
Breaking Medicine News(10 mins):